Hims & Hers shares rally on results, despite continued GLP-1 drug shortage

By MarketWatch | Nov 4, 2024 at 06:28 PM EST

Hims & Hers Health Inc. saw a surge in shares after raising its sales outlook due to increased demand for personalized care and weight-loss drugs. Despite popularity, drug shortages and competition remain a challenge, with executives highlighting ongoing supply constraints.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.